Tesamorelin, a growth hormone-releasing hormone (GHRH) analog, appears to act by binding to and activating the GHRH receptor on somatotrophs in the pituitary gland
A network meta-analysis of 22 RCTs covering 2,258 participants found GLP-1 receptor agonists reduced lean mass by a mean of 0.86 kg, with lean mass comprising roughly 25% of total weight lost across agents
Recreational steroid use may actually work against long-term wellness goals due to its potential impact on cardiovascular health, fertility, and hormone balance
Protein biomarkers discriminate Leishmania major-infected and non-infected individuals in areas endemic for cutaneous leishmaniasis
Although GLP-1 has been studied for decades, public interest has skyrocketed with the introduction of medications such as Ozempic, Wegovy, and Mounjaro, which target this hormone to help manage blood sugars and support weight loss